Kura Oncology Inc.

NASDAQ: KURA · Real-Time Price · USD
7.45
0.85 (12.88%)
At close: Aug 15, 2025, 2:34 PM

Kura Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-173.98M -152.63M -135.84M -130.47M
Depreciation & Amortization
848K 849K 759K 558K
Stock-Based Compensation
33.9M 28.08M 26.32M 23.58M
Other Working Capital
270.97M -2.51M -2.18M -706K
Other Non-Cash Items
-12.62M -8.94M 1.68M 399K
Deferred Income Tax
n/a n/a n/a 4.6M
Change in Working Capital
286.17M 7.82M -2.98M -3.22M
Operating Cash Flow
134.32M -124.82M -110.06M -104.55M
Capital Expenditures
-472K -168K -626K -1.15M
Cash Acquisitions
n/a n/a -33.25K 125.69K
Purchase of Investments
-659.05M -409.82M -270.65M -445.66M
Sales Maturities Of Investments
557.93M 425.55M 303.91M 319.97M
Other Investing Acitivies
n/a n/a 33.25K -125.69K
Investing Cash Flow
-101.59M 15.56M 32.63M -126.83M
Debt Repayment
n/a n/a 10M -7.25M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
8.6M 1.21M 3.84M -611K
Financial Cash Flow
154.42M 94.78M 38.56M -3.44M
Net Cash Flow
187.14M -14.48M -38.87M -234.82M
Free Cash Flow
133.84M -124.99M -110.69M -105.7M